Regeneron drug reduces bone growth for patients with ultra-rare skeletal disease

Biotech (General), Clinical Trials
Share:

Share:Patients with the ultra-rare disease FOP grow bone where it doesn’t belong, creating a life-threatening second skeleton. Regeneron Pharmaceuticals believes it can offer hope: A new treatment reduced new bone growth by 90% in a clinical trial, the company said, a result that could lead to Food and Drug Administration approval. More at:  https://www.statnews.com/2020/01/09/regeneron-drug-reduces-bone-growth-rare-skeletal-disease/

READ MORE

BrainStorm Cell Therapeutics Wins 2020 ‘Buzz of BIO’ Award for Investigational Cellular Treatment

Biotech (General), Biotech Stocks To Watch
Share:

Share:For its promising investigational therapeutic approach to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), BrainStorm Cell Therapeutics is the Buzz of BIO 2020 winner in the Public Therapeutic Biotech category. The Buzz of BIO contest identifies U.S. companies with groundbreaking, early-stage potential to improve lives. The event also is an opportunity to make investor […]

READ MORE

12 tips for safe social networking

Biotech (General)
Share:

Share:Social media is a fantastic development in human communications.  However, as with any technology, security should not be an afterthought.  Here is a very good list of simple security steps everyone should consider. https://www.networkworld.com/article/2870409/12–tips-for-safe-social-networking.html#slide4

READ MORE

How elephants avoid cancer

Biotech (General)
Share:

Share:Elephants have evolved extra copies of a gene that fights tumour cells, according to two independent studies1, 2 — offering an explanation for why the animals so rarely develop cancer. Why elephants do not get cancer is a famous conundrum that was posed — in a different form — by epidemiologist Richard Peto of the University of Oxford, UK, […]

READ MORE